Alternating chemotherapy in advanced gastric cancer

Jaime Feliú1, Carlos García Girón1, M. González‐Barón1, Alfonso Berrocal1, J. M. Barón-Saura1
1S. Oncología Médica. H. La Paz, U. A. M. Madrid, Madrid, Spain

Tóm tắt

Từ khóa


Tài liệu tham khảo

Coldman AJ, Goldie JH (1985) Role of mathematical modeling in protocol formulation in cancer chemotherapy. Cancer Treat Rep 9: 1041–1045

Klein HO, Wickramanayake PD, Farrkh GR (1986) 5-Fluoruracil (5-FU), adriamycin (ADM) and methotrexate (MTX) — A combination protocol (FAMTX) for treatment of metastasized stomach cancer. Proc Am Soc Clin Oncol 5:84

Lacave AJ, Antón-Aparicio L, González-Barón M, Estrada E, Fernán-dez-Hidalgo O, Barón FJ, Ribas A (1987) Cisplatin (CDDP) and 5-fluoruracil (5-FU) 120-h infusion for advanced gastric cancer (CG): a phase II multicenter study. Proc Am Soc Clin Oncol 6:91

Mac Donald JS, Schein PS, Wooley PV, Smythe T, Ueno W, Hoth D, Smith F, Boiron M, Gisselbretcht C, Brunet R, Lagarde C (1980) 5-Fluoruacil, doxorubicin and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med 93:533–536

Preuser P, Wilke H, Achterrath W, Fink U, Lenaz L, Heinicke A, Meyer J, Meyer HJ, Buente H (1989) Phase II study with the combination etoposide, doxorubicin and cisplatin in advanced measurable gastric cancer. J Clin Oncol 7:1310–1317

Suga S, Kimura K, Yokoyama Y, Iwase H, Isobe K, Shimaji T, Kitamura M, Ichimura T, Taniguchi S, Takahashi Y, Tamura Z (1983) UFT and UFTM treatment for gastric cancer. Drugs Exp Clin Res 9: 101–108